Hybrid Remote Trials: Trends and Applications

This market report was originally published in the Journal for Clinical Studies (Volume 12, Issue 5).

The COVID-19 pandemic reshaped the clinical trials landscape, prompting the rise of hybrid remote trials.

As traditional site visits became challenging due to social distancing and public health concerns, the industry adapted with innovative strategies to ensure trials continued effectively.

Hybrid trials combine in-person and remote methods, enabling the seamless collection of critical clinical endpoint data and maintaining patient care while minimizing disruptions.

Dive into this article to explore how hybrid remote trials are transforming clinical research and shaping the future of patient engagement.